CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.
May 31st 2024
When a group of people told me my non-Hodgkin lymphoma cure was a miracle, I realized it was only made possible because of health care professionals.
FDA Approves Rituxan Biosimilar to Treat Blood Cancers
July 23rd 2019The Food and Drug Administration approved Ruxience (rituximab-pvvr), a biosimilar to Rituxan (rituximab), for the treatment of certain adult patients with CD20-positive B-cell non-Hodgkin’s lymphoma and those with chronic lymphocytic leukemia.